KUKA market cap is €1.6 b, and annual revenue was €3.19 b in FY 2019

KUKA Revenue growth (FY, 2018 - FY, 2019), %(2%)

KUKA Gross profit (FY, 2019)677 M

KUKA Gross profit margin (FY, 2019), %21.2%

KUKA Net income (FY, 2019)17.8 M

KUKA EBITDA (FY, 2019)176.5 M

KUKA EBIT (FY, 2019)47.8 M

KUKA Cash, 31-Dec-2019584.8 M

KUKA EV1.7 B

KUKA revenue was €3.19 b in FY, 2019 which is a 1.5% year over year decrease from the previous period.

KUKA revenue breakdown by business segment: 13.6% from China, 6.6% from Swisslog Healthcare, 17.8% from Swisslog, 27.5% from Systems and 34.4% from Robotics

KUKA revenue breakdown by geographic segment: 21.6% from Other Regios, 31.8% from North America, 23.4% from Rest of Europe and 23.1% from Germany

EUR | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 |
---|---|---|---|---|

## Revenue | 2.9b | 3.5b | 3.2b | 3.2b |

| 18% | (7%) | (2%) | |

## Cost of goods sold | 2.2b | 2.7b | 2.5b | 2.5b |

## Gross profit | 766.5m | 754.3m | 725.9m | 677.0m |

| 26% | 22% | 22% | 21% |

## Sales and marketing expense | 267.9m | 306.7m | 319.9m | 291.6m |

## R&D expense | 126.6m | 128.7m | 151.9m | 160.5m |

## General and administrative expense | 228.2m | 211.4m | 246.7m | 190.4m |

## Operating expense total | 640.9m | 668.2m | 735.1m | 656.3m |

## Depreciation and amortization | 78.1m | 77.5m | 86.9m | 128.7m |

## EBITDA | 205.3m | 180.2m | 121.2m | 176.5m |

| 7% | 5% | 4% | 6% |

## EBIT | 127.2m | 102.7m | 34.3m | 47.8m |

| 4% | 3% | 1% | 1% |

## Interest expense | 13.0m | 15.2m | 13.4m | 19.9m |

## Interest income | 8.1m | 6.2m | 14.1m | 28.6m |

## Pre tax profit | 122.3m | 93.5m | 34.9m | 54.4m |

## Income tax expense | 36.1m | 5.3m | 18.3m | 36.6m |

## Net Income | 86.2m | 88.2m | 16.6m | 17.8m |

## EPS | 2.2 | 2.2 | 0.3 | 0.2 |

EUR | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 |
---|---|---|---|---|

## Cash | 364.2m | 223.6m | 478.6m | 584.8m |

## Accounts Receivable | 353.2m | 408.1m | 415.1m | 443.5m |

## Inventories | 318.8m | 387.4m | 466.8m | 344.5m |

## Current Assets | 1.7b | 1.7b | 2.0b | 2.0b |

## PP&E | 261.2m | 296.0m | 493.7m | 366.6m |

## Goodwill | 257.5m | 300.1m | 308.7m | |

## Total Assets | 2.5b | 2.6b | 3.2b | 3.4b |

## Accounts Payable | 459.3m | 549.2m | 402.7m | 402.3m |

## Short-term debt | 1.6m | 19.1m | 5.2m | 185.1m |

## Current Liabilities | 1.3b | 1.4b | 1.3b | 1.4b |

## Long-term debt | 249.6m | 249.7m | 380.5m | 487.8m |

## Non-Current Liabilities | 445.6m | 415.6m | 569.2m | 690.2m |

## Total Debt | 251.2m | 268.8m | 385.7m | 672.9m |

## Total Liabilities | 1.7b | 1.8b | 1.9b | 3.4b |

## Common Stock | 103.4m | 103.4m | 103.4m | 103.4m |

## Additional Paid-in Capital | 306.6m | 306.6m | 306.6m | 306.6m |

## Retained Earnings | 430.5m | 457.1m | 669.9m | 659.8m |

## Total Equity | 840.2m | 866.6m | 1.3b | 1.3b |

## Debt to Equity Ratio | 0.3 x | 0.3 x | 0.3 x | 0.5 x |

## Debt to Assets Ratio | 0.1 x | 0.1 x | 0.1 x | 0.2 x |

## Financial Leverage | 3 x | 3 x | 2.4 x | 2.5 x |

EUR | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 |
---|---|---|---|---|

## Net Income | 86.2m | 88.2m | 16.6m | 17.8m |

## Depreciation and Amortization | 78.1m | 77.5m | 86.9m | 91.9m |

## Accounts Receivable | (239.1m) | (75.9m) | 32.2m | 8.1m |

## Inventories | (22.8m) | (81.4m) | (74.1m) | 121.5m |

## Cash From Operating Activities | (9.6m) | 92.0m | (48.2m) | 214.5m |

## Capital Expenditures | (98.9m) | (140.1m) | (263.6m) | (151.1m) |

## Cash From Investing Activities | (97.2m) | (227.7m) | (165.5m) | (193.8m) |

## Dividends Paid | (19.3m) | (19.9m) | (19.9m) | (11.9m) |

## Cash From Financing Activities | (26.4m) | (10.7m) | 89.6m | 87.8m |

## Net Change in Cash | (132.0m) | (140.6m) | 255.0m | 106.2m |

## Interest Paid | 7.4m | 7.2m | 11.3m | 18.6m |

## Income Taxes Paid | 51.3m | 46.4m | 32.8m | 13.3m |

## Free Cash Flow | (108.5m) | (48.1m) | (311.8m) | 63.4m |

EUR | FY, 2016 |
---|---|

## EV/EBITDA | 16.4 x |

## EV/EBIT | 26.5 x |

## EV/CFO | -351.8 x |

## EV/FCF | -31.1 x |

## Revenue/Employee | 222.0k |

## Debt/Equity | 0.3 x |

## Debt/Assets | 0.1 x |

## Financial Leverage | 3 x |

## P/E Ratio | 39.8 |

FY, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | FY, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | FY, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | FY, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|

## Book-to-Bill Ratio | 116% | 122% | 100% | 101% | 104% | 121% | 113% | 88% | 102% | 121% | 113% | 75% | 100% |

## Book-to-bill Ratio (China) | 1 | ||||||||||||

## Book-to-bill Ratio (Robotics) | 110% | 102% | 102% | 89% | |||||||||

## Book-to-bill Ratio (Swisslog Healthcare) | 1.13 | ||||||||||||

## Book-to-bill Ratio (Swisslog) | 125% | 121% | 102% | 125% | |||||||||

## Book-to-bill Ratio (Systems) | 118% | 97% | 100% | 93% | |||||||||

## Order Backlog | €2.05 b | €2.26 b | €2.24 b | €2.21 b | €2.16 b | €2.33 b | €2.34 b | €2.20 b | €2.06 b | €2.20 b | €2.29 b | €2.06 b | €1.97 b |

## Orders Received | €3.42 b | €967.30 m | €1.01 b | €804.40 m | €3.61 b | €900.20 m | €960.20 m | €750.10 m | €3.31 b | €895.20 m | €914 m | €624.80 m | €3.19 b |

## Orders Received (China) | €456.40 m | ||||||||||||

## Orders Received (Robotics) | €1.09 b | €307.40 m | €1.22 b | €309.10 m | €1.18 b | €1.04 b | |||||||

## Orders Received (Swisslog Healthcare) | €251.30 m | ||||||||||||

## Orders Received (Swisslog) | €742.60 m | €230.20 m | €926.20 m | €241.10 m | €819.30 m | €750.20 m | |||||||

## Orders Received (Systems) | €1.64 b | €445.60 m | €1.53 b | €411.20 m | €1.30 b | €858 m |